NEOGENOMICS INC's ticker is and the CUSIP is 64049MAA8. A total of 21 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $495,000 | -62.6% | 588,000 | -63.0% | 0.00% | – |
Q2 2022 | $1,322,000 | +0.1% | 1,588,000 | +2.3% | 0.00% | – |
Q1 2022 | $1,321,000 | -27.3% | 1,553,000 | 0.0% | 0.00% | – |
Q4 2021 | $1,818,000 | -20.7% | 1,553,000 | 0.0% | 0.00% | – |
Q3 2021 | $2,292,000 | -14.6% | 1,553,000 | -17.9% | 0.00% | – |
Q2 2021 | $2,683,000 | -5.7% | 1,892,000 | 0.0% | 0.00% | – |
Q1 2021 | $2,845,000 | -6.9% | 1,892,000 | 0.0% | 0.00% | – |
Q4 2020 | $3,055,000 | +69.8% | 1,892,000 | +31.2% | 0.00% | – |
Q3 2020 | $1,799,000 | +71.0% | 1,442,000 | +48.4% | 0.00% | – |
Q2 2020 | $1,052,000 | – | 972,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 15,750,000 | $13,592,000 | 1.09% |
Context Capital Management, LLC | 13,000 | $11,214,000 | 0.73% |
ADVENT CAPITAL MANAGEMENT /DE/ | 19,422,000 | $16,659,000 | 0.27% |
WOLVERINE ASSET MANAGEMENT LLC | 18,386,000 | $15,685,000 | 0.15% |
Aequim Alternative Investments LP | 3,500,000 | $3,019,000 | 0.08% |
LINDEN ADVISORS LP | 12,066,000 | $10,358,000 | 0.06% |
CAPSTONE INVESTMENT ADVISORS, LLC | 23,500,000 | $20,269,000 | 0.06% |
LAZARD ASSET MANAGEMENT LLC | 15,000,000 | $12,937,000 | 0.02% |
D. E. Shaw & Co., Inc. | 16,900,000 | $14,517,000 | 0.01% |
BNP PARIBAS FINANCIAL MARKETS | 10,323,000 | $8,800,358,000 | 0.01% |